肝癌合并糖尿病围手术期处理87例临床分析  

Perioperafive management of patients with hepatocellular carcinoma complicated with diabetes mellitus:A report of 87 cases

作　　者：周健[1] 蒋辉[1] 张志浩[1] 

机构地区：[1]启东肝癌防治研究所,江苏226200

出　　处：《中国肿瘤临床与康复》2008年第6期537-539,共3页Chinese Journal of Clinical Oncology and Rehabilitation

摘　　要：目的总结肝癌合并糖尿病围手术期处理的经验。方法回顾性分析2005年1月至2007年8月我所收治的87例肝癌合并糖尿病的临床资料。结果87例患者中78例术前血糖控制在6.7～11.1 mmol/L,其中手术切口甲级愈合76例,乙级愈合(脂肪液化)2例,膈下感染1例;9例血糖控制在11.1～14.1 mmol/L,其中手术切口甲级愈合4例,乙级愈合(脂肪液化)5例,膈下感染4例。结论原发性肝癌合并糖尿病患者围手术期血糖控制至关重要,严密监测血糖、尿糖,规范围手术期胰岛素的强化治疗是预防术后并发症的关键。Objective To summarize the experience of perioperative management of the patients with hepatocellular carcinoma complicated with diabetes mellitus. Method Eighty-seven cases of diabetic patients with bepatocellular carcinoma were retrospectively analyzed. Results All of the 87 cases underwent hepatectomy. The blood glucose concentration in 78 cases was controlled preoperatively at 6. 7 mmol/L to 11. 1 mmol/L. The incisions of 76 and 2 cases achieved grade-A and grade-B healing respectively. One ease got subphrenic infection. The blood glucose concentration in 9 eases was controlled preoperatively at 11.1 mmol/L to 14. 1 mmol/L. The incisions of 4 and 5 cases achieved grade-A and grade-B healing respectively. Four cases got subphrenic infection. Conclusion It is very important to control perioperative blood glucose in patients with hepatocellular carcinoma complicated with diabetes mellitus. The monitoring of blood glucose and urine glucose, and standardization of perioperative intensive therapy with insulin are the keys to the prevention of postoperative complications.

关 键 词：肝肿瘤 糖尿病 胰岛素 手术后并发症 

分 类 号：R735.7[医药卫生—肿瘤] R730.6[医药卫生—临床医学]